ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 31 filers reported holding ARGOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,000 | 0.0% | 11,500 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -50.0% | 11,500 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -20.0% | 11,500 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | -92.4% | 11,500 | -14.8% | 0.00% | -100.0% |
| Q4 2016 | $66,000 | -1.5% | 13,500 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $67,000 | -18.3% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $82,000 | – | 13,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARXE AUSTIN W & GREENHOUSE DAVID M | 750,000 | $7,545,000 | 1.03% |
| WALL STREET ASSOCIATES | 475,100 | $4,780,000 | 0.49% |
| WASATCH ADVISORS LP | 1,158,344 | $11,653,000 | 0.12% |
| Pinnacle Summer Investments, Inc. | 92,415 | $929,000 | 0.10% |
| ALTRINSIC GLOBAL ADVISORS LLC | 250,000 | $2,515,000 | 0.05% |
| STONERIDGE INVESTMENT PARTNERS LLC | 25,811 | $260,000 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 22,704 | $228,000 | 0.03% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 701,900 | $7,061,000 | 0.02% |
| Alyeska Investment Group, L.P. | 79,430 | $799,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 500 | $5,000 | 0.01% |